key: cord-0257858-4tfgar8j authors: Watson, L. M. title: Simulating the impact of vaccination rates on the initial stages of a COVID-19 outbreak in New Zealand (Aotearoa) with a stochastic model date: 2021-11-24 journal: nan DOI: 10.1101/2021.11.22.21266721 sha: 0f587b4c2cced0f0ac0807b259d69f53764acdca doc_id: 257858 cord_uid: 4tfgar8j Aim: The August 2021 COVID-19 outbreak in Auckland has caused the New Zealand government to transition from an elimination strategy to suppression, which relies heavily on high vaccination rates in the population. As restrictions are eased and as COVID-19 leaks through the Auckland boundary, there is a need to understand how different levels of vaccination will impact the initial stages of COVID-19 outbreaks that are seeded around the country. Method: A stochastic branching process model is used to simulate the initial spread of a COVID-19 outbreak for different vaccination rates. Results: High vaccination rates are effective at minimizing the number of infections and hospitalizations. Increasing vaccination rates from 20% (approximate value at the start of the August 2021 outbreak) to 80% (approximate proposed target) of the total population can reduce the median number of infections that occur within the first four weeks of an outbreak from 1011 to 14 (25th and 75th quantiles of 545-1602 and 2-32 for V=20% and V=80%, respectively). As the vaccination rate increases, the number of breakthrough infections (infections in fully vaccinated individuals) and hospitalizations of vaccinated individuals increases. Unvaccinated individuals, however, are 3.3x more likely to be infected with COVID-19 and 25x more likely to be hospitalized. Conclusion: This work demonstrates the importance of vaccination in protecting individuals from COVID-19, preventing high caseloads, and minimizing the number of hospitalizations and hence limiting the pressure on the healthcare system. Results: High vaccination rates are effective at minimizing the number of infections and hospitalizations. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.22.21266721 doi: medRxiv preprint 3 In this work a stochastic branching process model 3-5 is used to simulate the initial stages of a COVID-19 69 outbreak within a community. Stochastic models are useful because they incorporate the randomness 70 associated with the initial stages of an outbreak. For some simulations, COVID-19 will spread widely and 71 form an extensive outbreak (e.g., Auckland in August 2021 where a returnee from Australia sparked an 72 outbreak with >6000 cases at the time of writing) whereas for other simulations, despite the virus having 73 a reproduction number larger than one, random chance will mean that COVID-19 does not spread far For a symptomatic individual, the Poisson distribution is defined by l= RC where R is the reproduction 108 number and C is the effectiveness of population level controls (e.g., Level 1, 2, 3, or 4 in the Alert Level CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint V=30%, there is a 10% chance that an outbreak will cause less than 98 infections after 28 days. However, 208 there is also a 10% chance that an outbreak will cause more than 1340 infections. The potential spread of 209 an outbreak is strongly dependent on the vaccination rate. For V=0%, there is a 50% chance than an 210 outbreak will cause less than 2691 infections after 28 days compared to less than 75 infections for 211 V=60%. The number of infections is strongly dependent on the vaccination rate with higher vaccination rates The results shown in Figures 2 and 3 illustrate how a vaccine can be extremely effective in preventing or The number of hospitalizations is also strongly dependent on the vaccination rate (Figure 4 ). For V=0%, 266 there is a 50% chance of over 282 hospitalizations 28 days into the outbreak compared to 50% chance of 267 less than 6 hospitalizations for V=60% and 1 hospitalization for V=90%. The hospitalization results 268 presented in Figure 4 are calculated for C=1, which gives a worst-case scenario. Implementation of 269 population level controls (i.e., Alert Level restrictions or vaccination certificates) will reduce the total Figure 5c shows that the probability that a 305 hospitalized case is vaccinated increases slower than the probability that an infected case is vaccinated. This shows that while the vaccine provides substantial protection against infection, it provides even 307 greater protection against hospitalization. At all vaccination rates, hospitalizations are significantly more 308 likely to be unvaccinated than vaccinated (at V=80%, there is an 86% chance that a hospitalized case will 309 be unvaccinated compared to 14% vaccinated). Figure 5d shows the probability of hospitalization . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint including the South Island. The government's switch from an elimination to suppression strategy has 328 emphasized the importance of vaccination in preventing COVID-19 from overwhelming the healthcare 329 system. As restrictions ease, there is a need to understand how different vaccination rates will impact the 330 initial stages of COVID-19 outbreak as cases become seeded in communities around New Zealand. Here, I use a stochastic branching process model to examine the impact of vaccination rates on the initial . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.22.21266721 doi: medRxiv preprint History of the COVID-19 Alert System Failures of quarantine systems for preventing COVID-19 351 outbreaks in Australia and New Zealand A stochastic model for COVID-19 spread and the effects 354 of alert level 4 in Aotearoa New Zealand. medRxiv Modeling the August 2021 COVID-19 outbreak in 356 New Zealand A COVID-19 vaccination model for Te Pūnaha Matatini Suppression and mitigation strategies for control of 360 COVID-19 in New Zealand CMMID COVID-19 working group, Eggo RM. Age-362 dependent effects in the transmission and control of COVID-19 epidemics Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant 366 (B.1.617.2): national case-control study. Lancet Reg Health Eur Mathematical modelling to inform New Zealand's COVID-369 19 response Estimating the extent of asymptomatic COVID-19 and 371 its potential for community transmission: systematic review and meta-analysis Crisanti 375 A; Imperial College COVID-19 Response Team Modelling to support a future COVID-19 strategy for Aotearoa 382 New Zealand Scientific Pandemic Influenza Group of Modeling, SPI-M-O. Summary of further modelling of 384 easing restrictions -Roadmap Step 4 Estimates of the severity of coronavirus disease 2019: a 388 model-based analysis COVID-19 Vaccine Data. Ministry of Health The Spinoff Covid-tracker: the live graphs that tell the story of delta in Aotearoa BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass 397 Vaccination Setting Big Read: Tracking the Covid-19 delta outbreak -how it arrived, simmered 400 through lockdown, then spread beyond reach. The New Zealand Herald The reproductive number of the Delta variant of SARS-CoV-2 is far higher 405 compared to the ancestral SARS-CoV-2 virus Non-pharmaceutical interventions, vaccination 409 and the Delta variant: epidemiological insights from modelling England's COVID-19 roadmap 410 out of lockdown. medRxiv SARS-CoV-2 Infections and Hospitalizations Among 412 MMWR Morb Mortal Wkly Rep 10 .15585/mmwr.mm7034e5. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.22.21266721 doi: medRxiv preprint